Drugs / Albumin-bound Paclitaxel (Ⅱ)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07828756 | Sep 2026 → Oct 2027 expected | malignant pancreatic neoplasm | Tianjin Medical University Cancer Institute and Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Albumin-bound Paclitaxel (Ⅱ) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07828756 ↗ |